We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+9.04%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$19.4B
AUM Growth
+$1.52B
Cap. Flow
+$55.8M
Cap. Flow %
0.29%
Top 10 Hldgs %
32.2%
Holding
350
New
17
Increased
136
Reduced
148
Closed
7

Top Buys

Rank Stock Value
1
PPL
PPL Corp
PPL
+$52.8M
2
OKE icon
Oneok
OKE
+$39.9M
3
MDLZ icon
Mondelez International
MDLZ
+$34.3M
4
HPQ icon
HP
HPQ
+$32.7M
5
TRV icon
Travelers Companies
TRV
+$32.4M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$52.6M
2
UPS icon
United Parcel Service
UPS
+$52.2M
3
CVX icon
Chevron
CVX
+$43.4M
4
ABT icon
Abbott
ABT
+$41.4M
5
ETN icon
Eaton
ETN
+$36.2M

Sector Composition

Rank Sector Weight
1 Technology 22.95%
2 Financials 14.09%
3 Healthcare 13.94%
4 Industrials 11.47%
5 Consumer Staples 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
201
Bristol-Myers Squibb
BMY
$132B
$2.34M 0.01%
45,263
+809
+2% +$38K
SHEL icon
202
Shell
SHEL
$245B
$2.3M 0.01%
34,850
CAT icon
203
Caterpillar
CAT
$387B
$2.27M 0.01%
5,807
+386
+7% +$133K
VIGI icon
204
Vanguard International Dividend Appreciation ETF
VIGI
$9.3B
$2.26M 0.01%
25,549
-4,547
-15% -$386K
AIT icon
205
Applied Industrial Technologies
AIT
$13.3B
$2.23M 0.01%
10,000
EL icon
206
Estee Lauder
EL
$32B
$2.23M 0.01%
22,332
-6,435
-22% -$610K
KMB icon
207
Kimberly-Clark
KMB
$36.5B
$2.19M 0.01%
15,358
CL icon
208
Colgate-Palmolive
CL
$74.4B
$2.1M 0.01%
20,205
-156
-0.8% -$15.9K
G icon
209
Genpact
G
$5.76B
$2M 0.01%
51,115
-7,282
-12% -$263K
MO icon
210
Altria Group
MO
$114B
$1.99M 0.01%
38,943
+24,254
+165% +$1.23M
VWO icon
211
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$1.96M 0.01%
41,006
+11,817
+40% +$526K
PFE icon
212
Pfizer
PFE
$153B
$1.92M 0.01%
66,504
-3,357
-5% -$97.9K
EFA icon
213
iShares MSCI EAFE ETF
EFA
$80.2B
$1.92M 0.01%
22,999
-4,679
-17% -$376K
PYPL icon
214
PayPal
PYPL
$50.5B
$1.82M 0.01%
23,325
LYB icon
215
LyondellBasell Industries
LYB
$19.2B
$1.8M 0.01%
18,793
-20
-0.1% -$1.92K
CLX icon
216
Clorox
CLX
$12.7B
$1.76M 0.01%
10,794
-2,612
-19% -$387K
GIS icon
217
General Mills
GIS
$19.7B
$1.76M 0.01%
23,779
-986
-4% -$68.3K
EOG icon
218
EOG Resources
EOG
$70.7B
$1.74M 0.01%
14,156
-25
-0.2% -$3.14K
AMT icon
219
American Tower
AMT
$80.4B
$1.71M 0.01%
7,372
-532
-7% -$118K
A icon
220
Agilent Technologies
A
$41.2B
$1.69M 0.01%
11,404
-442
-4% -$60.5K
ODFL icon
221
Old Dominion Freight Line
ODFL
$44.9B
$1.68M 0.01%
8,465
-1,385
-14% -$269K
MPLX icon
222
MPLX
MPLX
$59.7B
$1.68M 0.01%
37,800
+27,000
+250% +$1.15M
MMM icon
223
3M
MMM
$94.3B
$1.65M 0.01%
12,086
-660
-5% -$80.8K
STE icon
224
Steris
STE
$23.1B
$1.65M 0.01%
6,809
-375
-5% -$87.7K
GPC icon
225
Genuine Parts
GPC
$18.7B
$1.65M 0.01%
11,787
-100
-0.8% -$13.9K

Similar funds

Bahl & Gaynor's Q3 2024 Portfolio in Review

As of Q3 2024, Bahl & Gaynor held 350 positions worth $19.4B, up 8.5% from $17.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q3 2024 filing shows 17 new, 136 increased, 148 reduced and 7 closed positions. Its largest new stake was Gildan: 253,547 shares worth $11.9M. The largest sale was Amgen, an estimated $52.6M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q3 2024 buy was Gildan: 253,547 shares worth $11.9M.
  • Bahl & Gaynor added most to PPL Corp in Q3 2024, an estimated $52.8M increase.
  • Bahl & Gaynor's biggest Q3 2024 reduction was Amgen, cutting an estimated $52.6M.
  • Bahl & Gaynor fully exited Stepan Co in Q3 2024, selling an estimated $1.63M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $19.4B portfolio in Q3 2024.
  • Bahl & Gaynor opened 17 new positions and closed 7 in Q3 2024.
  • Bahl & Gaynor's portfolio value rose 8.5% quarter-over-quarter to $19.4B.

Based on Bahl & Gaynor's 13F filing for Q3 2024, filed 12 Nov 2024.